Back to search

Netherlands· NL-090b5c482747

Nexag 1000 mg, omhuld granulaat in sachet

A tranexamic acid product containing tranexaminezuur, registered in Netherlands by Cemag Care. The same ATC class is registered in 15 of our 19 countries.

ATC B02AA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNexag 1000 mg, omhuld granulaat in sa…ATCB02AA02REGISTER NO.NL-090b5c482747PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Tranexamic acid is registered in 15 of 19 countries.

Countries holding a registration under ATC B02AA02 (tranexamic acid), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Tranexamic acid · ATC B02AA02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tranexamic acid costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $1.69 in Italy to $34.44 in Switzerland — a ×20 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Tranexamic acid · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$34.44
  • IT Italy$1.69
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRANEXAMINEZUUR
Manufacturer
Cemag Care
Country
Netherlands (NL)
ATC code
B02AA02
ATC class
Tranexamic acid
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    129859

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

45 interactions on record for tranexamic acid.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tranexamic acid · interactions on record

45 records

  • 36 severe
  • 8 moderate
  • 1 minor

Most severe, free to view

  • Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
  • EstradiolD11AX34severe
  • IUP aus Plastik mit GestagenG02BA03severe
  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tranexamic acid in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tranexamic acid products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Cyklokapron, Tranexamsäure Baxter
  • Belgium · Acide Tranexamique Kabi, Cyklokapron
  • Bulgaria · Медокапрон, Т-Капрон
  • Cyprus · Azeptil, Medsamic
  • Czechia · Exacyl, Tranexamic Acid Accord
  • Germany · Cyklokapron, Cyklokapron-Injektionslösung
  • Denmark · Cyklokapron, Cyklonova
  • Estonia · Cyklokapron, Medsamic
  • Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
  • Finland · Caprilon, Cyklokapron
  • France · Acide Tranexamique Accord, Acide Tranexamique Aguettant
  • United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
  • Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
  • Croatia · Medsamic, Trenolk
  • Hungary · Exacyl, Nimra
  • Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
  • Iceland · Cyklokapron, Tranexamsyre Pfizer
  • Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
  • Lithuania · Haixa, Tranexamic Acid Baxter
  • Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
  • Latvia · Cyklokapron, Haixa
  • Malta · Azeptil, Medsamic
  • Norway · Cyklokapron, Pilexam
  • Poland · Deporium, Deporium Comfort
  • Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
  • Romania · Acid Tranexamic Kabi, Medsamic
  • Sweden · Cyklo-F, Cyklokapron
  • Slovenia · Medsamic, Trenolk
  • Slovakia · Medsamic, Tranexamic Acid Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/db7d0a49-92e8-4d59-b07c-d1a459cfb996
GET /v1/drugs/db7d0a49-92e8-4d59-b07c-d1a459cfb996?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Omhuld granulaat",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129859_smpc.pdf",
  "strength": null,
  "atc_label": "Tranexamic Acid",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129859",
  "excipients": [
    "COPOLYMEER VAN ETHYLACRYLAAT-METHYLMETHACRYLAAT (2:1) (E 1206)",
    "MAÏSZETMEEL",
    "NONOXINOL",
    "POVIDON K 30 (E 1201)",
    "SACCHAROSE",
    "SILICIUMDIOXIDE (E 551)",
    "SUCRALOSE (E 955)",
    "SUIKERZETMEELBOLLETJES",
    "TALK (E 553b)"
  ],
  "substances": [
    "TRANEXAMINEZUUR"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129859.pdf",
  "authorised_at": "2024/04/24",
  "procedure_number": "NL/H/5588/001",
  "dispensing_status": "Uitsluitend apotheek",
  "registration_number": "129859",
  "additional_monitoring": "N"
}

See everything about tranexamic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.